☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC May Update

The Scottish Medicines Consortium has issued its monthly advice on new medicines.

Aliskiren (Rasilez®) has been rejected for the treatment of essential hypertension. Escitalopram (Cipralex®) has been rejected for the treatment of social anxiety disorder. Both rejections we made because the manufacturers failed to make a submission.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected medicines should be avoided.

Share 'SMC May Update' by emailShare 'SMC May Update' on FacebookShare 'SMC May Update' on TwitterShare 'SMC May Update' on LinkedInShare 'SMC May Update' on reddit


No Comments to “SMC May Update”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.